EMEA-001957-PIP02-19-M01 - paediatric investigation plan
Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes
PIPHuman
Key facts
- Active Substance
- Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes
- Therapeutic area
- Congenital, familial and genetic disorders
- Decision number
- P/0291/2024
- PIP number
- EMEA-001957-PIP02-19-M01
- Pharmaceutical form(s)
- Dispersion for infusion
- Condition(s) / indication(s)
- Treatment of ataxia telangiectasia
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Quince Therapeutics S.p.A.
E-mail: info@quincetx.com
Tel.: +39 0236504470- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date